期刊文献+

心血管MR新技术在心脏瓣膜病中的应用进展 被引量:10

Application progresses of new cardiovascular MR techniques on valvular heart disease
下载PDF
导出
摘要 心脏瓣膜病(VHD)是老年人发生心血管事件的主要原因之一。影像学评估对诊断VHD及治疗决策至关重要。心血管MR(CMR)新技术在瓣膜病中的应用日益广泛,其中4D Flow MRI技术主要用于判断跨瓣血流速度、压差、壁剪切力、血流模式等血流动力学参数,T1 mapping/细胞外间质容积分数技术可定量评估继发于VHD的早期心室重构改变,心肌应变技术可监测早期心肌功能障碍。本文对CMR新技术在VHD中的应用进展进行综述。 Valvular heart disease (VHD) is one kind of the main causes of cardiovascular events in the elderly patients. Cardiac imaging evaluation plays a critical role in the diagnosis and selection of treatment options for VHD. New cardiovascular MR (CMR) techniques have been increasingly used for VHD patients, of which 4D Flow MRI-derived hemodynamic parameters can be used to estimate transvalvular blood flow velocities, pressure gradients, wall shear stress and flow patterns, T1 mapping and extracellular volume fraction enable quantification of changes of early ventricular remodeling secondary to VHD, strain analysis can be used to assess early myocardial dysfunction. The application progresses of new CMR techniques on VHD were reviewed in this article.
作者 郑育聪 赵世华 ZHENG Yucong;ZHAO Shihua(Department of MRI, National Center for Cardiovascular of China, Chinese cademy of Medical Sciences & Peking Union Medical College, Fuwai Hospital,Beijing 100037, China)
出处 《中国医学影像技术》 CSCD 北大核心 2019年第8期1244-1247,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金(81620108015、81571647)
关键词 心脏瓣膜疾病 磁共振成像 纵向弛豫时间定量成像 细胞外间质容积分数 heart valve diseases magnetic resonance imaging T1 mapping extracellular volume fraction
  • 相关文献

参考文献2

二级参考文献26

  • 1Mahrholdt H,Wagner A,Judd RM,et al.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies[J].Eur Heart J,2005,26:1461-1474.
  • 2Moon JC,Messroghli DR,Kellman P,et al.Myocardial T,mapping and extracellular volume quantification:a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement[J].J Cardiovasc Magn Reson,2013,15:92.
  • 3Weber KT.Cardiac interstitium in health and disease:the fibrillar collagen network[J].J Am Coll Cardiol,1989,13:1637-1652.
  • 4Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts[J].Cardiovasc Res, 2005, 65:40-51.
  • 5Moon JC,Reed E,Sheppard MN,et al.The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2004,43:2260-2264.
  • 6Kawel N,Nacif M,Zavodni A,et al.T1 mapping of the myocardium:intra-individual assessment of the effect of field strength,cardiac cycle and variation by myocardial region[J].J Cardiovasc Magn Reson,2012,14:27.
  • 7Gai N,Turkbey EB,Nazarian S,et al.T1 mapping of the gadolinium-enhanced myocardium:adjustment for factors affecting interpatient comparison[J].Magn Reson Med,2011,65:1407-1415.
  • 8Sharma P,Socolow J,Patel S,et al.Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5 T and 3 T in humans[J].J Magn Reson Imaging,2006,23:323-330.
  • 9Lee JJ,Liu S,Nacif MS,et al.Myocardial T1 and extracellular volume fraction mapping at 3 tesla[J].J Cardiovasc Magn Reson,2011,13:75.
  • 10Flett AS,Hayward MP,Ashworth MT,et al.Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis:preliminary validation in humans[J].Circulation,2010,122:138-144.

共引文献33

同被引文献47

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部